HbA@c decreased significantly at the end of treatment in the @ , @ , @ , and @mg luseogliflozin groups compared with placebo ( -@ , -@ , -@ , and -@ % , respectively , versus +@ % ; all P < @ ) , as did FPG and PPG ( all P < @ ) .